Deutsche Bank AG Ln End of Stabilisation Notice

  Deutsche Bank AG Ln - End of Stabilisation Notice

RNS Number : 8158Q
Deutsche Bank AG London
09 November 2012

Not for distribution, directly or indirectly, in or into the United States or
        any jurisdiction in which such distribution would be unlawful.

End of Stabilisation Notice

MD Medical Group Investments plc (the "Company")

Pursuant  to  Article  9(3)   of  Commission  Regulation  (EC)   No.2273/2003 
implementing the Market Abuse Directive (2003/6/EC), Deutsche Bank AG,  London 
Branch (Contact: Paul Huysmans; Telephone: 020 7547 4836) hereby gives  notice 
that stabilisation (within the meaning of the rules of the Financial  Services 
Authority) was undertaken by the  Stabilising Manager named below in  relation 
to the offer of the following securities.

Issuer:                                  MD Medical Group Investments plc    
Securities:                              Global Depositary Receipts          
Description of offer:                    Initial Public Offering             
ISIN Code:                               US55279C2008                        
Offer price:                             USD  12.00  per  Global  Depositary 
Stabilising Manager:                     Deutsche Bank AG, London Branch     
Stabilisation period:                    From 12 October 2012 to 9  November 

Trade Date Highest Price Paid (USD) Lowest Price Paid (USD)        
12/10/2012          12.00                    12.00
16/10/2012          12.00                    12.00
17/10/2012          12.00                    11.94
18/10/2012          11.94                    11.94
19/10/2012          11.94                    11.90
22/10/2012          11.90                    11.90
23/10/2012          11.90                    11.90
25/10/2012          12.00                    12.00
07/11/2012          12.00                    12.00

This announcement is for information purposes only and does not constitute  an 
invitation or  offer to  underwrite,  subscribe for  or otherwise  acquire  or 
dispose of any securities of MD Medical Group Investments in any jurisdiction.

The securities referred  to herein have  not been and  will not be  registered 
under the US Securities  Act of 1933, as  amended (the "Securities Act"),  and 
may not be offered or  sold in the United States  or to US persons unless  the 
securities are registered under the Securities  Act, or an exemption from  the 
registration requirements  of  the  Securities Act  is  available.  No  public 
offering of the securities will be made in the United States.

                     This information is provided by RNS
           The company news service from the London Stock Exchange


STABLBDBSXGBGDC -0- Nov/09/2012 17:01 GMT
Press spacebar to pause and continue. Press esc to stop.